Detalhe da pesquisa
1.
Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.
J Virol
; 85(12): 5764-72, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21490100
2.
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.
Proc Natl Acad Sci U S A
; 105(15): 5850-5, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18413606
3.
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.
Am J Pathol
; 174(1): 136-43, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19095951
4.
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.
J Virol
; 82(9): 4638-46, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18305047
5.
Role of L2 cysteines in papillomavirus infection and neutralization.
Virol J
; 6: 176, 2009 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-19860897
6.
A protective and broadly cross-neutralizing epitope of human papillomavirus L2.
J Virol
; 81(24): 13927-31, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17928339
7.
Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Cancer Res
; 66(23): 11120-4, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17145854
8.
Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus.
Virology
; 476: 405-412, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25591175
9.
Immune responses in macaques to a prototype recombinant adenovirus live oral human papillomavirus 16 vaccine.
Clin Vaccine Immunol
; 21(9): 1224-31, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24990902
10.
Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.
PLoS One
; 9(10): e109678, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25360552
11.
Serological relationship between cutaneous human papillomavirus types 5, 8 and 92.
J Gen Virol
; 90(Pt 1): 136-43, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19088282
12.
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity.
Vaccine
; 27(7): 1040-9, 2009 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19095032
13.
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.
J Natl Cancer Inst
; 101(11): 782-92, 2009 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19470949
14.
Generation and characterization of a preventive and therapeutic HPV DNA vaccine.
Vaccine
; 26(3): 351-60, 2008 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18096279
15.
HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice.
Vaccine
; 25(17): 3501-10, 2007 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16914239
16.
Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.
J Virol
; 81(21): 11585-92, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17715230
17.
A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.
Vaccine
; 25(11): 2001-10, 2007 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17239496
18.
Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection.
Vaccine
; 25(17): 3302-10, 2007 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-17291642
19.
Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection.
J Virol
; 79(11): 6723-31, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15890910
20.
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.
Virology
; 337(2): 365-72, 2005 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-15885736